Zydus Lifesciences Limited — Others, 12-08-2025: Shareholders meeting

Zydus Lifesciences' 30th Annual General Meeting concluded with shareholders approving all seven resolutions. This includes the adoption of the audited standalone and consolidated financial statements for the year ended March 31, 2025. A final dividend of Rs. 11 per equity share was also approved. Key re-appointments for Dr. Sharvil P. Patel as director and Mr. Ganesh N. Nayak as a Director in employment, with an annual remuneration of Rs. 3.60 Cr, received shareholder backing. Additionally, the remuneration of Rs. 0.085 Cr for Cost Auditors and the appointment of the Secretarial Auditor were ratified, ensuring continuity in governance and financial oversight.